Advagene Biopharma Co. Ltd.
6709StockTW
25.00 ▲ +1.63%
Jun 12, 2026
6
Advagene Biopharma Co. Ltd.
25.00 ▲ +1.63%
Jun 12, 2026
6709StockTW

About the company

Advagene Biopharma Co., Ltd. engages in the research and development of vaccine technology and related products in Taiwan. It engages in the development of nasal spray influenza vaccine; respiratory allergy treatment vaccine, including rhinitis and asthma; COVID-19 immunotherapy; and other vaccines. The company was founded in 2006 and is based in Taipei, Taiwan.

Arberion
Loading market data